Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Sanara MedTech Inc. SMTI

Healthcare  —  Medical Instruments & Supplies
35.06 (0.04) (0.11%) as of 25 Sep
Market cap
$322.5M
P/E
0.0×
Cash Flow Champion (3y) Revenue Champion (10y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Sanara MedTech Inc. (SMTI) Business Profile

Updated before January 2025

Company Overview

Sanara MedTech Inc. (SMTI) is a leading medical technology company specializing in advanced wound care and surgical products. Founded in 2014 and headquartered in Fort Worth, Texas, SMTI has rapidly grown to become a trusted name in the healthcare industry. The company is committed to improving patient outcomes through innovative solutions that address complex medical needs. SMTI’s leadership team includes experienced professionals with deep expertise in healthcare, medical technology, and business management. Key executives include Ron Nixon, Executive Chairman, and Zachary Fleming, Chief Executive Officer, who have been instrumental in driving the company’s strategic vision and operational success.

Core Business Segments

Sanara MedTech operates across two primary business segments: advanced wound care and surgical products. These segments are designed to address critical healthcare challenges and improve patient care.

Advanced Wound Care

SMTI offers a comprehensive portfolio of advanced wound care products aimed at promoting healing and reducing the risk of infection. Key products in this category include:

  • CellerateRX® Surgical Activated Collagen®: A patented collagen-based product designed to accelerate wound healing and reduce scarring.
  • HYCOL® Hydrolyzed Collagen: A topical gel that supports wound healing by providing essential nutrients to damaged tissue.
  • BIAKŌS™ Antimicrobial Wound Gel: A unique formulation that helps manage bioburden and prevent infection in chronic and acute wounds.

Surgical Products

SMTI’s surgical product line focuses on improving outcomes in surgical procedures. Key offerings include:

  • Fibracol® Plus Collagen Wound Dressing: A combination of collagen and alginate that promotes healing in surgical wounds.
  • Surgical Site Management Solutions: Products designed to reduce the risk of surgical site infections and improve post-operative recovery.

Business Model

Sanara MedTech’s business model is centered around integrating innovative products and services to deliver comprehensive solutions for healthcare providers and patients. The company generates revenue through the sale of its proprietary products, licensing agreements, and partnerships with healthcare institutions. SMTI also invests heavily in research and development to maintain its competitive edge and expand its product portfolio. By focusing on both product innovation and strategic collaborations, SMTI ensures a steady revenue stream while addressing unmet medical needs.

Strategic Direction

Sanara MedTech is committed to driving growth through innovation, sustainability, and market expansion. Key strategic initiatives include:

  • Product Development: Continued investment in R&D to introduce new products and enhance existing offerings.
  • Market Expansion: Expanding its presence in international markets to reach a broader patient population.
  • Sustainability Goals: Implementing eco-friendly practices in product development and manufacturing to reduce environmental impact.
  • Digital Health Integration: Exploring opportunities to integrate digital health solutions, such as telemedicine and remote patient monitoring, into its product offerings.

Competitive Landscape

Sanara MedTech operates in a highly competitive market, facing competition from both established players and emerging startups. Key competitors include:

  • Smith & Nephew: A global leader in advanced wound care and surgical products.
  • 3M Healthcare: Known for its comprehensive range of wound care solutions.
  • Convatec Group: Specializes in wound care, ostomy care, and continence care products.
  • Mölnlycke Health Care: Offers advanced wound care and surgical solutions.

Despite the competition, SMTI differentiates itself through its focus on innovation, quality, and patient-centric solutions.

Risk Factors

Sanara MedTech faces several risks that could impact its operations and financial performance. Key risk factors include:

  • Market Dependence: Reliance on the success of its core products and services for revenue generation.
  • Regulatory Challenges: Compliance with stringent healthcare regulations and approval processes.
  • Supply Chain Disruptions: Potential delays or shortages in raw materials and manufacturing components.
  • Competitive Pressure: Intense competition from established players and new entrants in the market.

Recent Developments

Sanara MedTech has made significant strides in recent years, including:

  • Product Launches: Introduction of new products such as BIAKŌS™ Antimicrobial Wound Gel, which has received positive feedback from healthcare providers.
  • Strategic Partnerships: Collaborations with leading healthcare institutions to expand its market reach and enhance product adoption.
  • Global Expansion: Entry into new international markets to diversify its revenue streams and reach more patients.
  • Technological Advancements: Investment in digital health technologies to complement its product offerings and improve patient outcomes.

Investment Considerations

Sanara MedTech offers several strengths and risks for potential investors to consider:

Strengths

  • Innovative Product Portfolio: A diverse range of proprietary products with strong market potential.
  • Experienced Leadership: A seasoned management team with a proven track record of success.
  • Growth Opportunities: Significant potential for market expansion and product development.

Risks

  • Market Volatility: Dependence on the healthcare sector, which is subject to regulatory and economic fluctuations.
  • Competitive Landscape: Intense competition from established players and new entrants.
  • Operational Risks: Challenges related to supply chain management and product manufacturing.

Conclusion

Sanara MedTech Inc. is a dynamic and innovative company poised for growth in the advanced wound care and surgical products market. With a strong focus on innovation, strategic partnerships, and market expansion, SMTI is well-positioned to address critical healthcare challenges and improve patient outcomes. While the company faces certain risks, its strengths and growth potential make it an attractive option for investors seeking exposure to the healthcare sector.